These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38047393)

  • 1. Associations Between Genetic Variation in the Targets of Low-Density Lipoprotein-Lowering Drugs and Rheumatoid Arthritis.
    Qin C; Hägg S
    Circ Genom Precis Med; 2024 Feb; 17(1):e004232. PubMed ID: 38047393
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
    Qiao L; Lv S; Meng K; Yang J
    Clin Rheumatol; 2024 Mar; 43(3):939-947. PubMed ID: 38198113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls.
    Liao KP; Diogo D; Cui J; Cai T; Okada Y; Gainer VS; Murphy SN; Gupta N; Mirel D; Ananthakrishnan AN; Szolovits P; Shaw SY; Raychaudhuri S; Churchill S; Kohane I; Karlson EW; Plenge RM
    Ann Rheum Dis; 2014 Jun; 73(6):1170-5. PubMed ID: 23716066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study.
    Qin C; Diaz-Gallo LM; Tang B; Wang Y; Nguyen TD; Harder A; Lu Y; Padyukov L; Askling J; Hägg S
    Eur J Epidemiol; 2023 Jul; 38(7):809-819. PubMed ID: 37052755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.
    Lorber M; Aviram M; Linn S; Scharf Y; Brook JG
    Br J Rheumatol; 1985 Aug; 24(3):250-5. PubMed ID: 3860273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
    Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
    J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab.
    Lee JS; Chapman MJ; Piraino P; Lamerz J; Schindler T; Cutler P; Dernick G
    Proteomics Clin Appl; 2016 Feb; 10(2):183-94. PubMed ID: 26201085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study.
    Zhang G; Cai Y; Liang J; Zhang J; Jing Z; Lv L; Zhang R; Song J; Dang X; Song Q
    Front Endocrinol (Lausanne); 2022; 13():961505. PubMed ID: 36120439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
    Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
    Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
    JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Siwan Traditional Therapy on Erythrocyte Sedimentation Rate, Lipid Profile, and Atherogenic Index as Cardiac Risk Factors Related to Rheumatoid Arthritis.
    Mahmoud NF; Allam NM; Omara II; Fouda HA
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676677
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
    Hurt-Camejo E; Paredes S; Masana L; Camejo G; Sartipy P; Rosengren B; Pedreno J; Vallve JC; Benito P; Wiklund O
    Arthritis Rheum; 2001 Dec; 44(12):2761-7. PubMed ID: 11762936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.
    Kononoff A; Elfving P; Pussinen P; Hörkkö S; Kautiainen H; Arstila L; Laasonen L; Savolainen E; Niinisalo H; Rutanen J; Marjoniemi O; Hämäläinen M; Vuolteenaho K; Moilanen E; Kaipiainen-Seppänen O
    Ann Med; 2020; 52(1-2):32-42. PubMed ID: 32011179
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.
    Vallvé JC; Paredes S; Girona J; Uliaque K; Ribalta J; Hurt-Camejo E; Masana L
    J Rheumatol; 2008 Sep; 35(9):1697-703. PubMed ID: 18634161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis.
    An J; Alemao E; Reynolds K; Kawabata H; Solomon DH; Liao KP; Niu F; Cheetham TC
    J Rheumatol; 2016 Nov; 43(11):1989-1996. PubMed ID: 27585690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation-related SNPs influence lipid levels and rheumatoid arthritis risk by altering gene expression and plasma protein levels.
    Mo X; Guo Y; Qian Q; Fu M; Zhang H
    Rheumatology (Oxford); 2020 Apr; 59(4):889-898. PubMed ID: 31624844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study.
    Yu Z; Zhang L; Zhang G; Xia K; Yang Q; Huang T; Fan D
    Ann Neurol; 2022 Sep; 92(3):390-399. PubMed ID: 35655417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study.
    Cao Y; Yang Y; Hu Q; Wei G
    J Transl Med; 2023 Sep; 21(1):616. PubMed ID: 37697373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Associations of Low Circulating Low-Density Lipoprotein Concentration With Subclinical Coronary Atherosclerosis.
    Giles JT; Wasko MCM; Chung CP; Szklo M; Blumenthal RS; Kao A; Bokhari S; Zartoshti A; Stein CM; Bathon JM
    Arthritis Rheumatol; 2019 Sep; 71(9):1426-1436. PubMed ID: 30883031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.